Investors' Hopes Riding on Surge in M&A Activity

Global mergers and acquisitions (M&A) activity is at its highest level since late 2009, providing a glimmer of hope to investors struggling to...

Japan's Astellas Pharma Is the Latest Company to Go Global to Dodge Patent Problems

Japan's second-largest drug maker Astellas Pharma, Inc. announced yesterday (Sunday) it would buy U.S. biotech OSI Pharmaceuticals, Inc. (Nasdaq:...

Pages 1 of 1